UTI, Nippon India Mutual Fund set aside Voda Idea debt
UTI Mutual Fund and Nippon India MF Monday decided to create a segregated portfolio, following in the footsteps of Franklin Templeton Mutual Fund, which had already segregated the investments last month.
Analyst Calls: BPCL, Muthoot Finance, Nestle, Ashok Leyland
IDBI Capital has maintained ‘buy’ rating on Muthoot Finance with a target price o...
Judge Trent, DMart by growth, not PE numbers: Yogesh Mehta
Yogesh Mehta, Founder, Yield Maximiser, says the play is now more on growth rather...
PSUs as a pack look attractive, but supply overhang persists: A Balasubramanian, Aditya Birla SL AMC
Balasubramanian finds PSU stocks attractive on high dividend yields and attractive price-to-book multiples that have fallen below one time in many cases. The government’s strategic sales holds the key, he said.
SBI not approached by any telco to finance AGR dues, says chairman
The comments on telecom companies come on a day when the Supreme Court made it clear that they will have to cough up the Rs 1.47 lakh crore in adjusted gross revenue (AGR) dues and also questioned why contempt proceedings should not be initiated against those who are coming in way of implementing its order.
Insurance looks promising, be selective in NBFCs: Vinay Sharma, Nippon Life India
Vinay Sharma, Equity Fund Manager, Nippon Life India Asset Management, says some momentum should come back in credit growth as we move forward next year. A combination of that keeps us positive on the banking sector as a whole, particularly on the corporate side of the financial sector. Edited excerpts.
LIC’s mega IPO is highly unlikely in FY21; here’s why
The chances of LIC IPO hitting the market in financial year 2021 is very low, given a slew of challenges.
Apple's coronavirus shock shows it is still handcuffed to the iPhone
Apple's earnings warning is an unfortunate reminder that it remain 'the iPhone company'.
Chakri Lokapriya is bullish on these consumer durable stocks
Chakri Lokapriya, CIO & MD, TCG AMC, says, you no longer have to spend on healthcare or life insurance to get I-T benefits, so one is now spending on smaller ticket items and companies like HUL and other consumer names will benefit.
Buy the momentum in DMart; SBI a re-rating candidate: Dipan Mehta
Dipan Mehta says invesors should refrain from questioning the market. If the market does not mind buying stocks at 60-70 PE where growth is 15-20 per cent, he says, so be it.
Rising agri income, cost cuts can help Hero Moto ride out bumps
Hero Moto has fallen 8% in 6 months, while its peers have gained up to 17% in the same period.
JB Chemicals valuations attractive: Analysts
NPPA notified one-time price increase of 50 per cent from existing ceiling price of select 21 National List of Essential Medicines products.
High liquidity driving ‘concentrated’ market rally: Sunil Subramaniam
Interest rates globally cannot go negative any further while gold prices cannot rise farther away, said Sunil Subramaniam, MD & CEO at Sundaram Mutual Fund. Equities will be the natural recipient of global liquidity, he said.
Invesco India Contra Fund: fund review
Among value schemes, investors can consider Invesco India Contra Fund, a distinguished performer.
Time for value buys over in insurance, chemical stocks: Ayon Mukhopadhayay, IIFL
Ayon Mukhopadhayay, Director, IIFL Securities Europe, says if you are looking for value buys in insurance and chemical sectors, that time is over but these are multi-year compounding stories with a potential to rerate but not massively.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service